Author Archives: Inês Martins PhD

AVEO Files New Patent Applications for AV-353, a Notch 3 Inhibitor Showing Promise as PAH Therapy

AVEO Oncology announced that it has filed provisional patent applications covering “composition of matter” claims for its Notch 3-specific inhibitory antibody, AV-353. The latest filings are the company’s second concerning its Notch 3 antibody program and AV-353. The Notch signaling pathway is involved in multiple cell fate decisions throughout human life,…